Thanks for the link TDA and the AGM info DufraneAnother teasing...

First 5 Last

Share
Profile

Follow
zeno9

204 Posts.

28

06/12/18

16:51

Post #: 36774593
Share

Originally posted by TDA: ↑

Interesting article as they got John Martin to actually talk of the fact upfront money is on the table and that it was 5 down to 3 companies.

“But investors are waiting for something very specific: a pending licencing deal in Japan for Progenza, an off-the-shelf treatment for osteoarthritis pain.
On the company’s indications, they might not be waiting for much longer with a deal expected by early next year or even by Christmas.

Regeneus is already in rarefied company in Japan, having struck a 50:50 partnership with the country’s biggest drug manufacturer, AGC.

The licencing partner would fund the phase II trials and be responsible for distribution.

CEO John Martin says Regeneus was interested in five potential licencing partners, which was whittled to three, all of which are currently in due diligence.
In up-front monetary terms, he says the offers are similar. “It’s not a case of whose money is better but whether it will deliver a better outcome in terms of phase II and marketing.”

Full article:

http://www.biotechdaily.com.au/media/Dr Boreham/RGS Nov 16 2018.pdf

Expand

Thanks for the link TDA and the AGM info Dufrane

Another teasing timeline for an announcement further on in the article (presumably about Cryoshot and RGS' vet pharma arrangements in the US) where John Martin states:

“We have an established relationship with one of the biggest vet pharma companies in theworld and we may have something to say about this over the next month or so.”

zeno9

RGS Price at posting: 20.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

CXM

'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 2 more messages in this thread...

First 5 Last

Add RGS (ASX) to my watchlist

Thanks for the link TDA and the AGM info DufraneAnother teasing...

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game